Holding company Blackhawk Growth Corp.BLRZF's subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its Phase 1 clinical trials microdosing LSD formulation in 80 ...

People who took twice-weekly low doses of LSD experienced no greater improvement in their ADHD symptoms than people taking placebo. Reading time 2 minutes LSD can do ...

The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...

The average scores decreased by 7 points in the LSD group and nearly 9 points in the placebo group, a difference not statistically significant to claim superiority of one treatment method over the ...

Share on Pinterest The use of psychedelic drugs such as LSD in mental health treatment is at the forefront of clinical research. Lyuba Burakova/Stocksy Psychedelic compounds have gained increased ...

New research lends further credibility to anecdotes that microdosing lysergic acid diethylamide (LSD), or taking too little of the psychedelic drug to trip but enough to feel effects, can help your ...

By the end of the six weeks, both the LSD and placebo groups had shown significant reductions in ADHD symptoms. On the primary measure, symptoms improved by an average of 7.1 points in the LSD group ...

Lysergic acid diethylamide used to be everywhere. LSD played a huge role in shaping pop culture in the 1960s, and in the 1980s everyone lived in fear of LSD-laced temporary tattoos and acid-popping ...

Low-dose treatment with lysergic acid diethylamide (LSD) failed to improve symptoms of attention deficit-hyperactivity disorder (ADHD) in adults, a double-blind randomized phase IIa trial showed.

LSD was first synthesized by Swiss chemist Albert Hofmann in 1938. He discovered its powerful psychoactive effects in 1943 after accidentally ingesting a small amount and experiencing vivid ...